Translating Clinical Trial Data Into New Patterns of Practice

Abstract

Get full access to this article

View all access options for this article.

References

Nathan DM

Buse JB

Davidson MB

, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963-1972.

Nathan DM

Buse JB

Davidson MB

, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2009;32: 193-203.

Buse JB

Evolution in the American Diabetes Association standards of care. Clin Diabetes. 2003;21:24-26.

Wettergren A.

Schjoldager B.

Mortensen PE

, et al. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci. 1993;38:665-673.

McIntosh CH

Incretin-based therapies for type 2 diabetes. Can Diabetes . 2008;32:131-139.

Byetta (exenatide injection) [package insert]. San Diego, CA: Amylin Pharmaceuticals Inc; 2007.

Peragallo-Dittko V.

Removing barriers to insulin therapy. Diabetes Educ. 2007;33:60S-65S.

Peyrot M.

Rubin RR

Access to diabetes self-management education. Diabetes Educ . 2008;34:90-97.

Mulcahy K.

Maryniuk M.

Peeples M.

Diabetes self-management education core outcomes measures. Diabetes Educ. 2003;29: 768-803.

10.

Rubin RR

Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus . Am J Med. 2005;118(Suppl 5A):27S-34S.